IMMUNOGENICITY AND PROTECTIVE EFFICACY IN A RHESUS-MONKEY MODEL OF VACCINE AC NFU1(S-) MRC AGAINST PRIMARY TYPE-2 HERPES-SIMPLEX VIRUS-INFECTION

  • 1 January 1982
    • journal article
    • research article
    • Vol. 63  (4) , 378-387
Abstract
Adult and juvenile Rhesus monkeys were vaccinated with subunit formaldehyde-inactivated vaccine Ac NFU1(S) MRC; no local or systemic side-effects followed vaccination. Vaccinated monkeys developed neutralizing and immunoprecipitating antibody to both type 1 and 2 herpes simplex virus. Antibody levels declined with time but were re-stimulated after virus challenge and to a lesser extent after attempted virus reactivation. There was evidence of protection against s.c. challenge with live type 2 herpes simplex virus.

This publication has 20 references indexed in Scilit: